Discover 1,859 paid clinical trials in Virginia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Virginia provides numerous opportunities for both healthy volunteers and people with specific medical conditions to participate in paid medical research. Major research centers in Richmond, Virginia Beach, and Norfolk are actively seeking participants, offering access to innovative treatments and advanced care.
Filter
1
Filter results
Results: 1,859
Ultrasound Findings in Diabetic Pregnancies
for
Diabetes
Location: Norfolk VA
Sponsor: Eastern Virginia Medical School
Sex: Female
Age: 18 - 45
Code: NCT06407388
Recruiting
Immune Response to C.Difficile Infection
for
Clostridium Difficile
Location: Charlottesville VA
Sponsor: University of Virginia
Sex: All
Age: 18+
Code: NCT02797288
Recruiting
Continuous Dual Aspiration Technique With Zoom System for Stroke
for
Ischemic Stroke, Acute Stroke
Location: New York NY, Albany NY, Baltimore MD, Falls Church VA,
Sponsor: Imperative Care, Inc.
Sex: All
Age: 18+
Code: NCT07491952
Recruiting
A Comparison of the dermaPACE® (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Care Versus Standard of Care Alone in the Treatment of Diabetic Foot Ulcers
for
Diabetic Foot Ulcers
Location: Hialeah FL, Miami FL, Roanoke VA, Kittaning PA,
Sponsor: SANUWAVE, Inc.
Sex: All
Age: 22+
Code: NCT01824407
Phase3, Recruiting
The Effect of a Mindset Management Approach on Stress Levels in Women With Infertility
for
Stress, Infertility, Female
Location: Roanoke VA
Sponsor: Virginia Polytechnic Institute and State University
Sex: Female
Age: 18 - 42
Code: NCT05997407
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
for
Non-small Cell Lung Cancer (NSCLC)
Location: Quebec, Westbury NY, New York NY, Montreal, Norfolk VA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07361497
Phase3, Recruiting
Stroke Thrombectomy and Aneurysm Registry
for
Stroke, Thromboses, Intracranial, Aneurysm, Brain
Location: Portsmouth NH, Boston MA, New Haven CT, Stony Brook NY,
Sponsor: Medical University of South Carolina
Sex: All
Age: 1 - 70+
Code: NCT04994756
Recruiting
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Boston MA, New York NY, Baltimore MD, Fairfax VA,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT05379985
Phase1, Phase2, Recruiting
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
for
Metastatic Dedifferentiated Liposarcoma,
Location: Boston MA, Baltimore MD, Bethesda MD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05711615
Phase1, Recruiting
PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
for
End Stage Renal Disease, Hemodialysis Access Failure
Location: Norfolk VA, Washington D.C. DC, Raleigh NC,
Sponsor: Merit Medical Systems, Inc.
Sex: All
Age: 18+
Code: NCT06422871
Recruiting
Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
for
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified,
Location: Charlottesville VA, Winston-Salem NC, Tampa FL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06015880
Phase1, Recruiting
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Brewer ME, Manchester NH, Worcester MA, Concord NH,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 0+
Code: NCT06031688
Phase2, Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC